Arkolith/Insider Trading/CLDI/Form 4

Schoeneck James A

DirectorCalidi Biotherapeutics, Inc. (CLDI) · full profile →Form 4 · filed Jun 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)375K$0.20$75K964K
Jun 3, 2024Option exercise(M)173K$0.20$35K589K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 3, 2024Option exercise(M)173K——202K
Jun 3, 2024Option exercise(M)173K——173K
Jun 3, 2024Option exercise(M)375K——375K
Jun 3, 2024Grant(A)548K——548K
Jun 3, 2024Option exercise(M)375K——0

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-022745) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Calidi Biotherapeutics, Inc.

Build

Ask your agent about CLDI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-24-022745"
Ask your agent
Use Arkolith to summarize insider buying and selling at Calidi Biotherapeutics, Inc.
over the last 90 days and cite the filings.